Home » Authors » Trista Morrison

Articles by Trista Morrison

NewCo News: Immune Design Gets $18M for Vaccines and Adjuvants

June 24, 2008

By Trista Morrison

FDA Summarizes Near-Term Goals as Conference Wraps

June 23, 2008

By Trista Morrison

Alternative Financing Strategies not a Cure-All for the Industry

June 20, 2008

By Trista Morrison

Department of Justice Turning Focus to Clinical Trial Conduct

June 19, 2008

By Trista Morrison

India: Moving from Services to Sustainable Innovation

June 18, 2008

By Trista Morrison

NewCo News: Kinexis Targets Alzheimer's Through Amyloid Oligomers

March 10, 2008

By Trista Morrison

Bevirimat Phase IIb Data Help Panacos Locate Responders

March 6, 2008

By Trista Morrison

Trevena Closes $24M Series A to Fund its GPCR Programs

March 5, 2008

By Trista Morrison

Trevena Closes $24M Series A to Fund its GPCR Programs

March 5, 2008

By Trista Morrison

Array Hits Pain Endpoints with Lead Drug ARRY-797

March 4, 2008

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...